BiotechTubeBiotechTube
Home/Supernus Pharmaceuticals/Jack A. Khattar
JA

Jack A. Khattar

President and Chief Executive Officer, Director

Supernus Pharmaceuticals

Roles

President and Chief Executive Officer, DirectoratSupernus Pharmaceuticals
DirectoratBioLineRx

Therapeutic Areas

NeurologyPsychiatryCentral Nervous System (CNS)

Supernus Pharmaceuticals Pipeline

DrugIndicationPhase
Qelbree® (viloxazine ER)Attention-Deficit/Hyperactivity Disorder (ADHD)Approved/Commercial
Trokendi XR®Epilepsy, Migraine PreventionApproved/Commercial
Oxtellar XR®EpilepsyApproved/Commercial
SPN-820/821Treatment-Resistant Depression (TRD)Phase 2
SPN-817Severe EpilepsyPhase 2
Adderall XR®ADHDApproved/Commercial
Intuniv®ADHDApproved/Commercial
Mydayis®ADHDApproved/Commercial

Leadership Team at Supernus Pharmaceuticals

TC
Timothy C. Dec
Senior Vice President, Chief Financial Officer
KT
Kevin T. Anderson, Esq.
Compliance Officer
JR
Jonathan Rubin
Employee (Featured in About Us video)
RL
Rebecca Lannan
Employee (Featured in About Us video)
CT
Chad Tasker
Employee (Featured in About Us video)
SM
Sarah Munoz
Employee (Featured in About Us video)
BR
Bryan Roecklein
Employee (Featured in About Us video)
KT
Konnie Taylor
Employee (Featured in About Us video)
RT
Roy Thomas
Employee (Featured in About Us video)
EA
Erin Agustinus
Employee (Featured in About Us video)
View full Supernus Pharmaceuticals profile